Anti-Oxidant Drugs: Novelties and Clinical Implications in Cerebellar Ataxias.
Conclusion Antioxidant therapy in cerebellar ataxias is a promising field of investigations. To achieve the success in identifying the correct treatment more work needs to be done. In particular, needed is a combined effort by basic scientists in developing more efficient molecules, and by clinical researchers together with patients communities, to run clinical trials in order to identify conclusive treatments strategies.
PMID: 29119930 [PubMed - as supplied by publisher]
Source: Current Neuropharmacology - Category: Drugs & Pharmacology Authors: Barca E, Emmanuele V, DiMauro S, Toscano A, Quinzii CM Tags: Curr Neuropharmacol Source Type: research
More News: Antidoxidants | Ataxia | Brain | Clinical Trials | Drugs & Pharmacology | Genetics | Neurology